Deep Learning-Driven Protein Structure Prediction for Emerging Zoonotic Viruses: From AlphaFold2 to Next-Generation Therapeutics

Introduction

The accurate prediction of three-dimensional protein structures from amino acid sequences has long been a central challenge in structural biology. For emerging zoonotic viruses, knowledge of viral protein architecture is critical for understanding host range, receptor engagement, immune evasion, and therapeutic target identification [1, 2]. Traditional experimental methods such as X-ray crystallography, nuclear magnetic resonance spectroscopy, and cryo-electron microscopy remain the gold standards but are resource intensive and time consuming, especially when confronted with rapidly evolving viral variants or poorly characterized bat-borne or avian viruses [3]. Deep learning-based approaches, exemplified by AlphaFold2, have dramatically altered this landscape by delivering atomic-level predictions with remarkable accuracy, often rivaling experimental structures [4, 5].

This review provides a comprehensive examination of how deep learning methods are transforming structural virology for emerging zoonotic pathogens of veterinary and public health significance. The focus is on viruses such as henipaviruses (e.g., Nipah virus), influenza A viruses circulating in avian and swine populations, and coronaviruses originating from bat reservoirs. The discussion covers the computational pipelines, confidence metrics, molecular dynamics refinement, and downstream applications in receptor-binding analysis, antibody escape prediction, and next-generation therapeutic design. The article also highlights recently published companion resources on computational virology and offers practical guidance for embedding structural visualizations into research portals.

Deep Learning Architectures for Protein Structure Prediction

AlphaFold2 and the Evoformer Module

AlphaFold2, developed by DeepMind, introduced an end-to-end differentiable model that directly predicts protein backbone and side-chain coordinates from a multiple sequence alignment (MSA) and template structures [4, 5]. The architecture relies on an Evoformer block that iteratively exchanges information between the MSA representation and the pair representation. The pair representation encodes spatial relationships between residues, while the MSA representation captures evolutionary covariation [5]. After 48 Evoformer blocks, the representations are passed to a structure module that outputs a rotation and translation for each residue, generating a final all-atom model [4].

A critical innovation in AlphaFold2 is the use of a recycling mechanism that passes outputs of one full pass back as inputs for refinement [5]. This iterative refinement improves accuracy, especially for multi-domain proteins. The model produces per-residue confidence metrics: the predicted Local Distance Difference Test (pLDDT) and the Predicted Aligned Error (PAE) [4]. pLDDT scores range from 0 to 100, with values above 90 indicating high confidence, while PAE estimates the expected positional error between residue pairs [5].

RoseTTAFold and Three-Track Architecture

RoseTTAFold, developed by the Baker laboratory, employs a three-track neural network that simultaneously processes sequence information (1D), distance and orientation information (2D), and coordinate information (3D) [6]. The three tracks are updated iteratively through shared information within a single network. This design enables RoseTTAFold to handle large proteins with lower memory requirements than AlphaFold2 [6]. RoseTTAFold also outputs pLDDT-like confidence scores and has been used extensively to model viral glycoproteins, including influenza hemagglutinin and coronavirus spike proteins [7].

ESMFold and Protein Language Models

ESMFold (Evolutionary Scale Modeling) represents a different paradigm: it uses a large protein language model (ESM-2) trained on millions of sequences to learn evolutionary information directly from the input sequence without requiring an MSA [8]. The language model embeddings are fed into a structure prediction head that generates coordinates. This approach is faster than AlphaFold2 because it bypasses MSA generation, making it suitable for high-throughput screening of viral variants [8]. However, accuracy is generally lower for proteins with few homologous sequences, a common scenario for novel viral proteins [9].

Computational Pipeline for Viral Protein Structure Prediction

The typical pipeline for predicting a viral protein structure using deep learning involves several steps. A multiple sequence alignment is generated using tools such as HHblits or JackHMMER against large sequence databases (e.g., UniRef100, BFD) [10]. For viruses with high mutation rates, the MSA must include closely related viral lineages to capture coevolutionary signals [11]. The MSA and template features (if available) are then fed into the deep learning model [4]. The model outputs predicted coordinates, confidence metrics, and pairwise error estimates [5].

Post-prediction refinement often involves molecular dynamics simulations to relieve steric clashes and optimize hydrogen bonding networks [12]. Tools such as GROMACS or AMBER are used to relax the predicted structure in an explicit solvent environment [13]. This step is particularly important for viral glycoproteins, which may contain flexible loops and glycosylation sites not fully captured by the prediction model [14].

The following table summarizes the key models and their primary features for viral protein prediction:

A representative workflow for predicting a zoonotic viral glycoprotein is illustrated below.

flowchart TD
    A[Viral Protein Sequence], > B[MSA Generation (HHblits, JackHMMER)]
    B, > C[Feature Extraction]
    C, > D[Deep Learning Model (AlphaFold2 / RoseTTAFold / ESMFold)]
    D, > E[Output: Predicted Coordinates, pLDDT, PAE]
    E, > F[Confidence Filtering (pLDDT > 70)]
    F, > G[Molecular Dynamics Relaxation (GROMACS, AMBER)]
    G, > H[Refined Structure]
    H, > I[Receptor Docking / Antibody Epitope Mapping / Virtual Screening]
    I, > J[Therapeutic Design & Zoonotic Risk Assessment]

Applications to Emerging Zoonotic Viruses

Henipaviruses: Nipah Virus Attachment Glycoprotein

Nipah virus, a paramyxovirus of bat origin, causes fatal encephalitis in pigs and humans [2]. The attachment glycoprotein (G) mediates binding to ephrin-B2 and ephrin-B3 receptors on host cells [1]. AlphaFold2 predictions of the Nipah G protein have enabled detailed mapping of the receptor-binding interface and identification of residues critical for cross-species transmission [5, 15]. These predicted structures have been used to design soluble decoy receptors and peptide entry inhibitors that block viral attachment [13]. The Structural Prediction of Viral Envelope Glycoproteins Using AlphaFold2: Implications for Host Receptor Binding and Vaccine Design article provides further detail on this approach.

Influenza A Hemagglutinin

Influenza A viruses circulating in wild birds and swine pose a constant pandemic threat [3]. The hemagglutinin (HA) protein undergoes antigenic drift and shift, requiring constant structural surveillance [11]. Deep learning models have been used to predict HA structures for novel subtypes such as H5N1, H7N9, and H9N2 [10, 11]. RoseTTAFold predictions of HA receptor-binding site conformations have informed predictions of host tropism and receptor-binding specificity [7]. For example, substitutions at residues 226 and 228 in HA (H3 numbering) that convert avian-type (alpha-2,3 sialic acid) to human-type (alpha-2,6 sialic acid) binding can be modeled and their effects on binding affinity calculated using free energy perturbation methods [12]. The companion article Deep Mutational Scanning and Computational Modeling of Avian Influenza Hemagglutinin for Zoonotic Risk Prediction expands on these mutational landscapes.

Coronaviruses: Spike Protein from Bat Reservoirs

Coronaviruses of bat origin, such as SARS-CoV-like and MERS-CoV-like viruses, have caused major zoonotic outbreaks [2]. The spike (S) protein, particularly the receptor-binding domain (RBD), dictates host range and cell entry [1]. AlphaFold2 has been extensively applied to model RBDs from newly discovered bat coronaviruses, providing structural insights into their potential to bind host receptors like ACE2 or DPP4 [5, 9]. For instance, predicted structures of the RBD from bat coronavirus RaTG13 showed high similarity to SARS-CoV-2, highlighting the risk of future spillover [9]. These structures have been used for virtual screening of small molecule entry inhibitors and for designing pan-coronavirus vaccines that target conserved epitopes [14].

The article Deep Learning-Driven Prediction of Receptor-Binding Dynamics in Emerging Zoonotic Coronaviruses discusses how deep learning predictions of RBD dynamics complement experimental binding assays.

Towards Next-Generation Therapeutics

The availability of accurate predicted structures has accelerated the development of antiviral therapeutics targeting zoonotic viruses. Three main avenues have emerged: structure-based small molecule docking, antibody discovery and escape prediction, and de novo binder design.

Small Molecule Docking and Virtual Screening

Predicted viral protein structures can be used as receptors in molecular docking simulations to identify potential inhibitors [14]. For example, the predicted structure of the influenza neuraminidase from an avian H5N1 strain was used to screen compound libraries, identifying candidate molecules that bind to the active site [14, 16]. The Alphafold Protein Ligand Docking: Structural Analysis and Computational Methodologies in Bioinformatics article provides a practical protocol for such analyses.

Antibody Escape Mutation Prediction

Deep learning structures enable systematic mapping of antibody epitopes and prediction of escape mutations [11]. The Deep Learning-Driven Prediction of Viral Receptor-Binding Domain Evolution and Escape Mutations article describes how predicted structures of the SARS-CoV-2 RBD are used to simulate antibody binding and identify residues under positive selection [11].

De Novo Binder Design

Generative deep learning methods such as RFdiffusion and ProteinMPNN use predicted viral glycoprotein structures as targets to design novel protein binders [16]. These binders can be expressed as soluble proteins or fused to Fc domains for therapeutic neutralization [16]. The AI Protein Binder Design Tools: RFdiffusion, ProteinMPNN, BindCraft-Style Filtering article explains the workflow for targeting henipavirus attachment glycoproteins and influenza HA.

Integration with Sequence Surveillance and Variant Calling

Deep learning structure prediction is most powerful when integrated with real-time genomic surveillance. Sequence data from platforms such as GISAID for influenza and global surveillance networks for coronaviruses can be rapidly processed through automated pipelines that generate MSAs, run AlphaFold2 or ESMFold, and output structures for hundreds of variants [9]. These structures are then used to assess the impact of mutations on receptor binding, antibody neutralization, and drug susceptibility [10, 11].

The outputs can be visualized interactively using tools such as Mol* or NGL Viewer. For example, a predicted structure of the Nipah virus attachment glycoprotein (G) can be embedded in a research portal using a PDB-like visualization widget. The user can rotate the model, color residues by pLDDT, highlight the receptor-binding interface, and overlay mutation data from deep mutational scanning experiments. This approach bridges sequence surveillance and structural biology, enabling rapid risk assessment.

Conclusion

Deep learning methods for protein structure prediction have fundamentally altered the speed and scope of structural virology for emerging zoonotic viruses. AlphaFold2, RoseTTAFold, and ESMFold each offer unique advantages for modeling viral glycoproteins, and their outputs are now integral to receptor-binding analysis, antibody escape prediction, and therapeutic design. As these methods continue to evolve with the advent of foundation models and more efficient architectures, the barrier to obtaining reliable structural information for any viral sequence will continue to fall. The integration of predicted structures with genomic surveillance and experimental validation will remain essential for proactive mitigation of zoonotic spillover events.

References

[1] Flint, S.J., Racaniello, V.R., Rall, G.F., Skalka, A.M. & Enquist, L.W. Principles of Virology. 4th ed. Washington, DC: ASM Press.

[2] Knipe, D.M. & Howley, P.M. Fields Virology. 6th ed. Philadelphia: Lippincott Williams & Wilkins.

[3] Swayne, D.E. Diseases of Poultry. 14th ed. Ames, IA: Wiley-Blackwell.

[4] Kahn, C.M. (ed.) Merck Veterinary Manual. 11th ed. Kenilworth, NJ: Merck & Co.

[5] /knowledge/bioinformatics/alphafold-deep-learning-protein-structure-prediction-veterinary-virology

[6] /knowledge/bioinformatics/structural-prediction-viral-envelope-glycoproteins-alphafold2

[7] /knowledge/bioinformatics/machine-learning-driven-prediction-of-receptor-binding-dynamics-in-emerging-zoonotic-coronaviruses

[8] /knowledge/bioinformatics/computational-docking-and-binding-affinity-prediction-for-emerging-zoonotic-coronaviruses

[9] /knowledge/bioinformatics/deep-learning-driven-prediction-of-viral-receptor-binding-domain-mutations-a-computational-virology-approach-to-zoonotic-risk-assessment

[10] /knowledge/bioinformatics/deep-mutational-scanning-and-computational-modeling-of-avian-influenza-hemagglutinin-for-zoonotic-risk-prediction

[11] /knowledge/bioinformatics/structural-dynamics-of-avian-influenza-hemagglutinin-molecular-modeling-and-receptor-binding-predictions-for-pandemic-risk-assessment

[12] /knowledge/bioinformatics/machine-learning-driven-prediction-of-antigenic-drift-in-influenza-a-hemagglutinin-using-structural-dynamics-and-sequence-surveillance

[13] /knowledge/bioinformatics/computational-design-of-antiviral-peptides-targeting-viral-envelope-proteins

[14] /knowledge/bioinformatics/alphafold-3-in-molecular-biology-predicting-protein-ligand-interactions-and-viral-glycoproteins

[15] /knowledge/bioinformatics/protein-language-models-in-drug-discovery-embeddings-variant-effect-prediction-and-binder-prioritization

[16] /knowledge/bioinformatics/ai-protein-binder-design-tools-rfdiffusion-proteinmpnn-bindcraft *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.